alunbrig - brigatinib tablet, film coated
(Brigatinib)Takeda Pharmaceuticals America, Inc.
Usage: Alunbrig treats adult patients with ALK-positive metastatic non-small cell lung cancer (NSCLC) as detected by an FDA-approved test.
Tyrosine Kinase Inhibitors [MoA] class drugs
7 results
ayvakit - avapritinib tablet, film coated
(Avapritinib)Blueprint Medicines CorporationUsage: Ayvakit treats adults with unresectable or metastatic GIST harboring PDGFRA exon 18 mutations (including D842V), advanced systemic mastocytosis (ASM, SM-AHN, mast cell leukemia), and indolent systemic mastocytosis. Not recommended when platelet counts are below 50 × 10⁹/L.calquence
(Acalabrutinib)Astrazeneca Pharmaceuticals Lpcalquence - acalabrutinib tablet, film coated
(Acalabrutinib)Astrazeneca Pharmaceuticals LpUsage: CALQUENCE treats adults with mantle cell lymphoma (MCL) — either previously untreated (with bendamustine and rituximab, when ineligible for stem cell transplant) or after prior therapy — and adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).tukysa - tucatinib tablet
(Tucatinib)Seagen Inc.Usage: Tukysa is used with trastuzumab and capecitabine for HER2-positive metastatic breast cancer (including brain metastases) in adults after prior anti-HER2 therapy. Also used with trastuzumab for RAS wild-type, HER2-positive metastatic colorectal cancer after prior chemotherapy.vonjo - pacritinib capsule
(Pacritinib)Sobi, Inc.Usage: Vonjo treats adults with intermediate or high-risk primary or secondary myelofibrosis (post-polycythemia vera or post-essential thrombocythemia) with a platelet count below 50 × 10⁹/L. Approved under accelerated approval based on spleen volume reduction.zykadia - ceritinib tablet, film coated
(Ceritinib)Novartis Pharmaceuticals Corporation